Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
There are many ongoing advances in the multidisciplinary management of stage III NSCLC, in particular the advent of neoadjuvant immunotherapy in patients who are resectable.
Category
  • Immunotherapy
  • Thoracic
Format
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
How to Say No
Live Webinar
Category
  • Professional Development
Format
  • Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00

Pages